<html>
	<head>
		<title>schering-plough <sgp> gets fda approval</title>
		<meta name="keywords" content="places usa">
</head>
<body>
	<h3>schering-plough corp said its elocon topical steroid for inflammatory skin disorders has been approved for marketing by the u.s. food and drug administration in cream and ointment forms for once-daily applications.     the company said overseas health agency registrations for elocon are scheduled to be submitted in a number of major markets this year and in other areas in 1988.  reuter &#3;</h3>
</body>
</html>